Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | References |
Rattus norvegicus | Hydroxyacid oxidase 2 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0602 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0602 | 1 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0602 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0214 | 0.2745 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0214 | 0.2745 | 0.2745 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.2745 | 0.2745 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0602 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0602 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0214 | 0.2745 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.2745 | 0.2745 |
Entamoeba histolytica | isopentenyl-diphosphate delta-isomerase, putative | 0.0075 | 0.0136 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0602 | 1 | 1 |
Mycobacterium leprae | POSSIBLE L-LACTATE DEHYDROGENASE (CYTOCHROME) LLDD2 | 0.0209 | 0.2638 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0602 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0214 | 0.2745 | 0.2745 |
Schistosoma mansoni | brg-1 associated factor | 0.0602 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0602 | 1 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0214 | 0.2745 | 0.2745 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0602 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0214 | 0.2745 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0214 | 0.2745 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0602 | 1 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0602 | 1 | 1 |
Mycobacterium tuberculosis | Possible L-lactate dehydrogenase (cytochrome) LldD2 | 0.0209 | 0.2638 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0602 | 1 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0214 | 0.2745 | 0.2745 |
Brugia malayi | brahma associated protein 60 kDa | 0.0602 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0602 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0214 | 0.2745 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0602 | 1 | 1 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0602 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0602 | 1 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0214 | 0.2745 | 0.5 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0602 | 1 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0602 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0214 | 0.2745 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0214 | 0.2745 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.0214 | 0.2745 | 0.2745 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0214 | 0.2745 | 0.5 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0214 | 0.2745 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0602 | 1 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Treponema pallidum | hypothetical protein | 0.0209 | 0.2638 | 0.5 |
Mycobacterium ulcerans | L-lactate dehydrogenase (cytochrome) LldD2 | 0.0209 | 0.2638 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0602 | 1 | 1 |
Onchocerca volvulus | 0.0602 | 1 | 1 | |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0602 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.2745 | 0.2745 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0214 | 0.2745 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.2745 | 0.2745 |
Leishmania major | hypothetical protein, conserved | 0.0214 | 0.2745 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0214 | 0.2745 | 0.2745 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0214 | 0.2745 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Induction of PXR at 100 uM | ChEMBL. | 24900281 | |
Activity (functional) | Agonist activity at human GPR109a at 10 uM | ChEMBL. | 24900281 | |
IC50 (binding) | = 0.3 uM | Inhibition of rat His6-tagged Hao2 expressed in Escherichia coli BL21/DE3 using 2-hydroxyoctanoic acid as substrate measured every 10 secs by spectrophotometry | ChEMBL. | 24900281 |
IC50 (binding) | = 0.3 uM | Inhibition of rat Hao2-mediated oxidation of 2-hydroxyoctanoic acid assessed as proportionate release of H2O2 | ChEMBL. | 22658862 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP3A4 | ChEMBL. | 24900281 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C9 | ChEMBL. | 24900281 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2D6 | ChEMBL. | 24900281 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP2C19 | ChEMBL. | 24900281 |
IC50 (ADMET) | > 10 uM | Inhibition of CYP1A2 | ChEMBL. | 24900281 |
IC50 (ADMET) | > 100 uM | Cytotoxicity against human HepG2 cells | ChEMBL. | 24900281 |
Inhibition (binding) | Inhibition of rat His6-tagged Hao1 expressed in Escherichia coli BL21/DE3 using glcolic acid as substrate at 10 uM measured every 10 secs by spectrophotometry | ChEMBL. | 24900281 | |
Inhibition (binding) | = 8 % | Inhibition of human Hao2-mediated oxidation of 2-hydroxyoctanoic acid assessed as proportionate release of H2O2 at 1 uM | ChEMBL. | 22658862 |
Inhibition (binding) | = 29 % | Inhibition of human Hao2-mediated oxidation of 2-hydroxyoctanoic acid assessed as proportionate release of H2O2 at 10 uM | ChEMBL. | 22658862 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.